SIRT1: a Potential Tumour Biomarker and Therapeutic Target.

Bin Zhao,Xin Li,Liangfu Zhou,Ye Wang,Peng Shang
DOI: https://doi.org/10.1080/1061186x.2019.1605519
2019-01-01
Journal of Drug Targeting
Abstract:SIRT1, which is highly homologous to yeast silent information regulator 2, has recently garnered tremendous attention because of its various regulatory effects in several pathological conditions. Numerous studies have found that SIRT1 is highly expressed in a broad range of tumours compared with the paracancerous tissue. However, the role of SIRT1 in malignancies has yet to be systematically elucidated, and its use as a promising biomarker or therapeutic target for tumours has not been well-reported. Herein, we focus on the roles of SIRT1 in cancers and summarise the potential use of SIRT1 as a promising tumour biomarker or therapeutic target.
What problem does this paper attempt to address?